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ABSTRACT
Transient receptor potential (TRP) mucolipins (TRPMLs), encoded
by the MCOLN genes, are patho-physiologically relevant endo-
lysosomal ion channels crucial for membrane trafficking. Several
lines of evidence suggest that TRPMLs mediate localised Ca2+
release but their role in Ca2+ signalling is not clear. Here, we show that
activation of endogenous and recombinant TRPMLs with synthetic
agonists evoked global Ca2+ signals in human cells. These signals
were blocked by a dominant-negative TRPML1 construct and a
TRPML antagonist. We further show that, despite a predominant
lysosomal localisation, TRPML1 supports both Ca2+ release and
Ca2+ entry. Ca2+ release required lysosomal and ER Ca2+ stores
suggesting that TRPMLs, like other endo-lysosomal Ca2+ channels,
are capable of ‘chatter’ with ER Ca2+ channels. Our data identify new
modalities for TRPML1 action.
KEY WORDS: Ca2+, Lysosomes, TRP channels, Endoplasmic
reticulum
INTRODUCTION
The remarkable versatility of Ca2+ as an intracellular messenger is
underpinned by the spatiotemporal organisation of Ca2+ signals
(Berridge et al., 2003). Targeted delivery of Ca2+ to a particular
subcellular locale is one way in which Ca2+ can selectively
influence a particular cell outcome (e.g. secretion). Equally, global
Ca2+ signals, which are often oscillatory, can also be selective
through information encoded in oscillation frequency. Interplay
between Ca2+ release from intracellular Ca2+ stores and Ca2+ influx
from the extracellular space ensures tight control of Ca2+ levels and
their downstream targets (Clapham, 2007). Although we have
gained much mechanistic insight into the mobilisation of ER Ca2+
stores and the subsequent entry of Ca2+ across the plasmamembrane
that ensues (Prakriya and Lewis, 2015), we know relatively little
about Ca2+ handling by acidic Ca2+ stores such as lysosomes (Patel
and Muallem, 2011).
Lysosomes are best known for their degradative role but they
maintain an intraluminal Ca2+ concentration (∼500 µM) similar to
the ER (Christensen et al., 2002; Lloyd-Evans et al., 2008). They are
likely filled by Ca2+-H+ exchange (Melchionda et al., 2016) and
express members of the transient receptor potential mucolipin
(TRPML) and two-pore channel (TPC) families to effect Ca2+
release (Grimm et al., 2012; Kiselyov et al., 2012; Patel, 2015;
Waller-Evans and Lloyd-Evans, 2015). Three TRPML isoforms are
present in humans (García-Añoveros and Wiwatpanit, 2014).
TRPML1 (encoded by MCOLN1) is ubiquitously expressed and
targets to lysosomes through di-leucine motifs (Vergarajauregui and
Puertollano, 2006). It is activated by the endo-lysosomal
phosphoinositide phosphatidylinositol 3,5-bisphosphate [PI(3,5)
P2] (Dong et al., 2010) and is a non-selective cation channel
permeable to a number of ions including Ca2+ and Fe2+ (Dong et al.,
2008). Importantly, mutation of TRPML1 results in the lysosomal
storage disorder mucolipidosis type IV (Bargal et al., 2000). This
neurodegenerative disorder is characterised by build-up of various
lipid species in lysosomes, suggesting a role for TRPML1 in lipid
trafficking. It has long been recognised that localised Ca2+ release
from the endo-lysosomal system can influence vesicular fusion and
fission events (Pryor et al., 2000). Specifically, Ca2+ release through
TRPMLs likely underlies functional roles in vesicular trafficking as
well as lysosomal exocytosis (Samie et al., 2013), autophagy
(Medina et al., 2015) and regulated secretion (Park et al., 2016).
Notably, recently described TRPML agonists have proven
beneficial in correcting trafficking defects not only in
mucolipidosis type IV (Chen et al., 2014) but also in Niemann–
Pick type C disease (Shen et al., 2012) and HIV-associated
dementia (Bae et al., 2014). Defective TRPML activity has also
been implicated in Alzheimer’s disease (Lee et al., 2015). Despite
their demonstrable (patho)physiological relevance, TRPML-
mediated Ca2+ signals are difficult to resolve due to their
localised nature. To overcome this, a number of recent studies
have used genetically encoded Ca2+ indicators such as GCaMP-3 or
GECO fused directly to TRPML1 to record Ca2+ signals in response
to agonist activation (Bae et al., 2014; Cao et al., 2015; Medina
et al., 2015; Shen et al., 2012). These signals are suggested to reflect
local peri-lysosomal Ca2+ release. But it is not clear how the
relatively high-affinity Ca2+ indicators used distinguish between
local and global Ca2+ signals.
In addition to supporting local Ca2+ fluxes required for endocytic
‘well-being’ (Hockey et al., 2015), lysosomes can also initiate
global Ca2+ signals during signalling. This process has been
established in the context of the actions of the messenger nicotinic
acid adenine dinucleotide phosphate (NAADP) (Galione, 2015).
According to the trigger hypothesis, increases in NAADP levels
activate endo-lysosomal Ca2+ channels, generating local Ca2+
signals that sensitise neighbouring Ca2+ release channels on the ER.
Activation of the latter (on the more substantial store) results in
global Ca2+ release. Indeed, in fibroblasts, direct mobilisation of
lysosomal Ca2+ stores through osmotic permeabilisation is
sufficient to trigger ER-dependent complex Ca2+ signalsReceived 15 April 2016; Accepted 19 August 2016
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(Kilpatrick et al., 2013). Physiologically, it is the TPCs that have
emerged as the target channels for NAADP (Brailoiu et al., 2009;
Calcraft et al., 2009; Patel, 2015) although a role for TRPMLs has
also been advanced (Zhang et al., 2011, but see Yamaguchi et al.,
2011). Coupling between TPCs and ER Ca2+ channels likely occurs
at membrane contact sites between lysosomes and the ER
(Kilpatrick et al., 2013; Patel and Brailoiu, 2012; Penny et al.,
2014). Although TRPMLs can evoke global Ca2+ entry, at least
when mutated as exemplified by the Va mutation in TRPML3
(encoded by MCOLN3) (Grimm et al., 2007; Kim et al., 2007),
whether they support lysosome–ER cross talk is not known.
Here, we take advantage of TRPML agonists ML-SA1 (Shen
et al., 2012) and MK6-83 (Chen et al., 2014) to probe the Ca2+
permeability of TRPMLs in an intact cell setting. We show that
activation of TRPML1 unexpectedly evokes global Ca2+ signals.
Mechanistically, we dissect these signals into release and influx
components implicating both ER and extracellular Ca2+, in addition
to lysosomal Ca2+, for their genesis. Our data suggest that the action
of TRPML1 is not limited to local lysosomal Ca2+ signalling.
RESULTS
TRPML agonists evoke global Ca2+ signals
Fusion proteins comprising TRPML1 and either GCaMP-3 (Shen
et al., 2012) or GECO (Cao et al., 2015) have been used to resolve
presumed local Ca2+ fluxes from lysosomes upon TRPML1
activation. But as shown in Fig. 1A and Movie 1, Ca2+ responses
to ML-SA1 (20 µM) were readily resolvable in a proportion of Hela
cells loaded with the fluorescent Ca2+ indicator Fura-2. This organic
dye distributes throughout the cytosol and thus records bulk changes
in cytosolic Ca2+.ML-SA1 responses were concentration dependent
(Fig. 1A). Similar results were obtained using primary cultured
human fibroblasts. As in HeLa cells, ML-SA1 evoked strong Ca2+
responses in Fura-2-loaded cells in a concentration-dependent
manner (Fig. 1B; Movie 2). The amplitude of the Ca2+ signals and
the proportion of responsive cells are quantified in Fig. 1C,D.
Fibroblasts were more responsive than HeLa cells, although we
noted considerable variability between experiments, particularly for
fibroblasts (Fig. 1D). To probe specificity, we examined the effects
of the new TRPML antagonists ML-SI1 and ML-SI3 (Samie et al.,
2013). ML-SI1 could not be used because it evoked Ca2+ signals
(Fig. S1A). ML-SI3, however, inhibited ML-SA1-evoked Ca2+
signals (Fig. 1E,F). Collectively, these data suggest that, contrary to
the prevailing view, activation of endogenous TRPMLs is capable
of evoking global Ca2+ signals.
Agonist-evoked Ca2+ signals require TRPML1
To investigate the mechanism underlying agonist-evoked Ca2+
signals, we examined the effects of expressing active TRPML1 and
inactive TRPML1 mutated within the pore region (TRPML1D471K)
(Yamaguchi et al., 2011). Confocal analyses of HeLa cells
expressing TRPML1 and TRPML1D471K revealed a comparable
punctate distribution consistent with localisation to lysosomes
(Fig. 2A). Accordingly, there was marked colocalisation of both
proteins with lysotracker (a fluorescent acidotrope) and LAMP1 (a
lysosomal marker) (Fig. 2B–E).
In control experiments, ML-SA1 evoked Ca2+ signals in cells
expressing LAMP1 (Fig. 3A). The responses were similar to those
in un-transfected cells (Fig. 1). In cells expressing TRPML1,
however, there was a large potentiation of the Ca2+ signal (Fig. 3A)
such that essentially all of the cells responded (Fig. 3B,C). The
potentiating effect of TRPML1 was specific because it was not
observed with TRPML1D471K (Fig. 3A–C). Similar results were
obtained in fibroblasts (Fig. S1C,D) although this analysis was more
limited due to the difficulty in transfecting these cells. Notably, ML-
SA1-evoked Ca2+ signals were inhibited in cells expressing
TRPML1D471K relative to cells expressing LAMP1 (Fig. 3A–C).
The inhibitory effect of TRPML1D471K is likely due to dominant-
negative activity resulting from oligomerisation with endogenous
TRPML1 (Venkatachalam et al., 2006).
We also tested the effect of the structurally distinct mucolipin
analogue MK6-83. Like ML-SA1, MK6-83 evoked large Ca2+
signals in cells expressing TRPML1 but not TRPML1D471K
(Fig. 3D,E). Ca2+ signals evoked by both ML-SA1 and MK6-83
in TRPML1-expressing cells were blocked by ML-SI3 (Fig. 3F–I).
These molecular and chemical analyses establish the requirement
for TRPML1 in global Ca2+ signalling.
TRPML1 couples lysosomal and ER Ca2+ release
To define the Ca2+ sources underlying TRPML1-dependent Ca2+
signals, we first established the relative contribution of store release
and Ca2+ entry to the evoked responses. As shown in Fig. 4A,B,
removal of extracellular Ca2+ reduced the peak response upon
ML-SA1 stimulation and eliminated the sustained phase. ML-SA1-
evoked Ca2+ signals in Ca2+-free medium were TRPML1
dependent, as judged by the lack of ML-SA1-evoked Ca2+ signals
in TRPML1D471K-expressing cells and upon treatment withML-SI3
(Fig. 4C). These data suggest that ML-SA1 evokes both Ca2+
release and Ca2+ influx.
We used the lysosomotropic agent Gly-Phe β-naphthylamide
(GPN) to disrupt lysosomes. This dipeptide causes osmotic
destabilisation of lysosomes and other cathepsin-C-positive
compartments (Jadot et al., 1984). GPN treatment resulted in a
rapid loss of Lysotracker® red fluorescence consistent with its action
on lysosomes (Fig. S1E,F) and inhibited the responses to ML-SA1
indicating a requirement for lysosomes in ML-SA1-evoked Ca2+
release (Fig. 4D). These data are consistent with the lysosomal
localisation of TRPMLs (Fig. 2). However, despite the complete
compromise of lysosomes upon GPN treatment, the resulting Ca2+
signals were modest relative to those evoked by ML-SA1 (Fig. 4D).
This suggested that ML-SA1 did not exclusively release Ca2+ from
the lysosomes.
We considered the possibility that activation of TRPMLs might
be followed by Ca2+ release from the ER in a manner similar to
activation of TPCs by NAADP (Cancela et al., 1999; Patel et al.,
2010). To test this, we examined the effects of ML-SA1 after
depleting ER Ca2+ stores with thapsigargin. As shown in Fig. 4D,
thapsigargin treatment blocked the responses to ML-SA1 indicating
a clear requirement for ER Ca2+ stores inML-SA1 action. To further
probe the role of the ER, we used 2-APB to block inositol 1,4,5-
trisphosphate (IP3) receptors. As shown in Fig. 4D, 2-APB
(100 µM) inhibited ML-SA1-evoked responses. A summary of
these data is provided in Fig. 4E. We conclude that activation of
TRPMLs on lysosomes triggers Ca2+ release from the ER.
TRPML1 mediates Ca2+ influx
Finally, we examined the nature of the Ca2+ entry pathway evoked
by TRPML1 activation. Because store-operated Ca2+ entry is a
ubiquitous pathway underlying Ca2+ influx in non-excitable cells,
we tested the effects of the Ca2+ entry inhibitor BTP2. BTP2
(20 µM) completely prevented Ca2+ signals evoked by Ca2+ add-
back following depletion of ER Ca2+ stores with thapsigargin
(Fig. S2A,B). However, BTP2 did not affect the amplitude of Ca2+
signals evoked byML-SA1 (Fig. 5A,B) although it did slow the rate
of rise (Fig. S2C). These data suggest that store-operated Ca2+ entry
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Fig. 1. The TRP mucolipin agonist ML-SA1 evokes global Ca2+ signals. (A–D) Effect of ML-SA1 on cytosolic Ca2+ levels. Cytosolic Ca2+ levels of individual
Fura-2-loaded HeLa cells (A) or fibroblasts (B) from an exemplar population stimulated with increasing concentrations of ML-SA1. (C,D) Summary data
quantifying the peak response (C) and percentage of responsive cells within the population (D). Each data point represents an independent repetition. A total of
350–788 HeLa cells and 81–140 fibroblasts were analysed. (E,F) Effect of the mucolipin inhibitor ML-SI3 on agonist-evoked Ca2+ signals. (E) Cytosolic Ca2+
levels of HeLa cells stimulated with 20 µM ML-SA1 in the presence of vehicle (0.1% DMSO) or 10 µM ML-SI3. (F) Summary data for the experiments in E (366–
406 cells).
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does not play a major role in Ca2+ signals evoked by TRPML1
activation.
The above data raised the possibility that TRPML1 might mediate
Ca2+ entry more directly. To test this, we examined the effects ofML-
SA1 on Fe2+ entry. Fe2+ permeates TRPML1 and, like several other
metal ions, quenches Fura-2 fluorescence (Dong et al., 2008). Fura-2-
loaded HeLa cells were therefore challenged with FeCl2 (1 mM) in
nominally Ca2+-free medium after stimulation with ML-SA1. FeCl2
induced a significant quench of Fura-2 fluorescence in cells
expressing TRPML1 (Fig. 5C). This effect was blocked by ML-SI3
(Fig. 5C,D) and was not observed in cells expressing TRPML1D471K
(Fig. 5G,H). Similar results were obtained upon stimulation with
Fig. 2. Subcellular distribution of TRPML1.
(A) Confocal fluorescence images (green) of fixed
HeLa cells expressing GFP-tagged LAMP1 (left),
TRPML1 (middle) or TRPML1D471K (right). Nuclei
were stained using DAPI (blue). (B,C) Confocal
fluorescence images of cells expressing GFP–
TRPML1 or GFP–TRPML1D471K and either
colabelledwith Lysotracker®Red (LTR) and imaged
live (B) or co-transfected with LAMP1-mRFP and
imaged following fixation (C). Overlays of images
are shown in the right panels where arrows
delineate the regions from which red–green
intensity plots were derived. Scale bar: 10 µm.
(D,E) Summary data of experiments in
C quantifying Pearson’s correlation coefficients
(D) and the percentage of vesicles showing
colocalisation (E). Each point represents an
individual cell from two independent transfections.
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Fig. 3. Agonist-evoked Ca2+ signals require TRPML1. (A–C) Effect of TRPML expression on ML-SA1-evoked Ca2+ signals. (A) Cytosolic Ca2+ levels of
individual LAMP1, TRPML1- or TRPML1D471K-expressing HeLa cells stimulated with 20 µM ML-SA1. (B,C) Summary data of experiments in Awhere each data
point represents an independent repetition. The total number of cells analysed was 193–367. (D,E) Effect of TRPML expression onMK6-83-evoked Ca2+ signals.
(D) Cytosolic Ca2+ levels of individual TRPML1- or TRPML1D471K-expressing HeLa cells stimulated with 20 µM MK6-83. (E) Summary data of experiments in D
(111–128 cells). (F–I) Effect of ML-SI3 on agonist-evoked Ca2+ signals. Cytosolic Ca2+ levels of individual TRPML1-expressing HeLa cells stimulated with 20 µM
ML-SA1 (F) or 20 µM MK6-83 (H) in the presence of vehicle (0.1% DMSO) or 10 µM ML-SI3. Summary data are shown in panels (G; 120 cells) and (I; 101–107
cells), respectively.
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Fig. 4. TRPML1 couples lysosomal and ER Ca2+ release. (A,B) Effect of extracellular Ca2+ on agonist-evoked Ca2+ responses. (A) Cytosolic Ca2+ levels of
TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 in Ca2+-containing or Ca2+-free Hepes-buffered saline. (B) Summary data of experiments in A
where each data point represents an independent repetition. The total number of cells analysed was 184–284. (C) Cytosolic Ca2+ levels of TRPML1 or
TRPML1D471K-expressing HeLa cells stimulated with 20 µMML-SA1 with or without 10 µMML-SI3 in Ca2+-free medium. (D,E) Effect of disrupting Ca2+ stores on
agonist-evoked Ca2+ responses. (D) Cytosolic Ca2+ levels of TRPML1-expressing HeLa cells stimulated with 20 µMML-SA1 following pre-treatment with DMSO,
200 µM GPN, 1 µM thapsigargin or 100 µM 2-APB. (E) Summary data of experiments in D (71–462 cells). Experiments were performed in Ca2+-free medium.
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Fig. 5. TRPML1 mediates Ca2+ influx. (A,B) Effect of blocking store-operated Ca2+ influx on agonist-evoked Ca2+ responses. (A) Cytosolic Ca2+ levels of
TRPML1-expressing HeLa cells stimulated with 20 µM ML-SA1 in the presence of vehicle (0.1% DMSO) or 20 µM BTP2. (B) Summary data of experiments in A
where each data point represents an independent repetition. The total number of cells analysed was 151–173. (C–J) Effect of TRPML1 activation on Fe ion entry.
HeLa cells expressing TRPML1 were stimulated with 20 µM ML-SA1 (C) or MK6-83 (E) and then 1 mM FeCl2 in the presence of vehicle (0.1% DMSO) or 10 µM
ML-SI3. HeLa cells expressing TRPML1D471K were stimulated with either 20 µM ML-SA1 or MK6-83 (G). HeLa cells expressing TRPML1 were stimulated with
20 µM ML-SA1 and either 1 mM FeCl2 or 1 mM FeCl3 (I). Experiments were performed in nominally Ca
2+-free medium. Fluorescence signals (denoted F) were
recorded after excitation at the isosbestic wavelength of Fura-2 (360 nm) and normalised to that at the beginning of recording (denoted F0). Summary data (D,F,H,
J; for C,E,G and I, respectively) quantifying the fractional loss of fluorescence 144s after addition of Fe2+ or Fe3+ under the various conditions (80–169 cells).
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MK6-83 (Fig. 5E–H). Challengewith FeCl3 (1 mM) after stimulation
with ML-SA1 was without effect (Fig. 5I,J) attesting to specificity.
BTP2 slowed Fe2+ entry (Fig. S2D,E), however, add-back of Fe2+
following depletion of Ca2+ stores with thapsigargin did not result in a
significant quench (Fig. S2F,G).
Collectively, these data provide evidence that TRPML1 supports
divalent cation entry across the plasma membrane.
DISCUSSION
In this study, we have shown that activation of TRPMLs by two
structurally distinct agonists, in both a human cell line and primary
cultures, evokes global Ca2+ signals. These data indicate that
TRPMLs do not solely mediate local Ca2+ release events from endo-
lysosomal compartments. Indeed, we provide evidence that
activation of TRPMLs can evoke both Ca2+ release and Ca2+ entry.
We have dissected global Ca2+ release signals into both
lysosomal and ER components. There is much evidence
supporting the transmission of Ca2+ signals from endo-lysosomes
to the ER but to date such ‘chatter’ has been ascribed exclusively to
the actions of NAADP and TPCs (Patel and Brailoiu, 2012). Our
study extends such coupling to TRPMLs, raising the possibility that
other Ca2+-permeable endo-lysosomal channels such as P2X4
receptors and TRPM2 might also functionally couple to ER Ca2+
release channels (Patel and Cai, 2015).
Inhibition of TRPML1 byplasmamembrane PI(4,5)P2 is thought to
ensure channel activation only in endo-lysosomal compartments
(Zhang et al., 2012). In accordancewith this idea, basal (unstimulated)
whole-cell currents are not detectable in TRPML1-expressing cells.
SF-51 (Grimm et al., 2010), the precursor to ML-SA1, however, has
been reported to mediate a TRPML1 plasma membrane current
(Zhang et al., 2012) consistent with our Ca2+ and Fe2+ entry
measurements. Divalent cation entry might therefore result from
targeting of a small fraction of TRPML1 to the plasma membrane.
Although blockade of store-operated channels reduced TRPML1-
dependent Ca2+ and Fe2+ entry (albeit modestly), the amplitude of the
Ca2+ signal upon maximal Ca2+ ER store depletion was substantially
smaller than that evoked by agonist activation. Indeed, store-operated
Fe2+ entry was not demonstrable under our conditions. These data
raise the possibility that BTP2 might directly inhibit TRPML1 similar
to its effects on TRP-canonical (TRPC) channels (He et al., 2005).
The multi-compartment actions of TRPML1 offer fresh
perspective on interpreting Ca2+ signals recorded using Ca2+
reporters fused to TRPML1 (Bae et al., 2014; Cao et al., 2015;
Medina et al., 2015; Shen et al., 2012). We suggest that such signals
might additionally reflect Ca2+ release from the ER and Ca2+ entry.
Indeed, defects in Ca2+ signals reported using such indicators in
scenarios of TRPML1 dysfunction are perplexing given that
expression of TRPML1 is able to rescue phenotypic defects such
as lysosomal storage (Cao et al., 2015; Shen et al., 2012). Use of
inert lysosomal proteins for targeting (McCue et al., 2013) and/or
low-affinity Ca2+ indicators, to better insulate against bulk cytosolic
Ca2+ changes, might aid in isolating local lysosomal Ca2+ release
events. Finally, how TRPMLs are endogenously activated remains
to be established, but PI(3,5)P2 is a clear candidate raising the
possibility that changes in its levels in response to cues such as
growth factors might regulate global Ca2+ dynamics.
MATERIALS AND METHODS
Cell culture
HeLa cells and primary cultured human skin fibroblasts from healthy
individuals (Kilpatrick et al., 2013) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal
bovine serum, 100 units/ml penicillin and 100 µg/ml streptomycin (all from
Invitrogen) at 37°C in a humidified atmosphere with 5% CO2. Cells were
passaged using trypsin (HeLa) or scraping (fibroblasts) and plated onto
13-mm glass coverslips prior to microscopy. For HeLa cells, coverslips were
coated with poly-L-lysine (Sigma). Cells were transfected with plasmids
using Lipofectamine 2000 according to the manufacturer’s instructions.
Plasmids encoding the following proteins were described previously: C-
terminally GFP-tagged LAMP1 (Falcón-Pérez et al., 2005), C-terminally
mRFP-tagged LAMP1 (Sherer et al., 2003) and N-terminally GFP-tagged
wild-type or D471K human TRPML1 (Yamaguchi et al., 2011).
Cell labelling
All live imaging experiments were performed in HEPES-buffered saline
(HBS) comprising (in mM): 1.25 KH2PO4, 2 CaCl2, 2 MgSO4, 3 KCl, 156
NaCl, 10 glucose, and 10 HEPES (pH 7.4; all from Sigma). For
measurement of cytosolic Ca2+ concentration and Fe2+ or Fe3+ entry, cells
were incubated with Fura-2 AM (2.5 µM) and 0.005% v/v pluronic acid
(from Invitrogen) for 1 h. For measurement of lysosome distribution, cells
were incubated with Lysotracker® Red (100 nM) (Invitrogen) for 15 min.
After labelling, cells were washed with HBS andmounted in a 1-ml imaging
chamber (Biosciences Tools) prior to microscopy. For measurement of
colocalisation, cells were co-transfected with GFP–TRPML1 or GFP–
TRPML1D471K together with LAMP1–mRFP and fixed with 4%
paraformaldehyde prior to confocal microscopy. For visualisation of
nuclei, cells were incubated with 1 µg/ml DAPI for 5 min.
Epifluorescence microscopy
Epifluorescence imageswere captured every 3 s with a cooled coupled device
camera (TILL photonics) attached to anOlympus IX71 inverted fluorescence
microscope fitted with a 20× objective, and a monochromator light source.
Fura-2 was excited at 340, 360 or 380 nm, and Lysotracker® Red at 560 nm.
Emitted fluorescence was captured using a 440-nm long-pass filter (Fura-2)
and 590-nm filter (Lysotracker® Red). TRPML1-expressing cells were
identified by monitoring fluorescence of GFP (excitation 488 nm, emission
505 nm). Cells were stimulated with ML-SA1, GW405833 hydrochloride
(Sigma; also known as ML-SI1, Haoxing Xu, Department of Molecular,
Cellular, and Developmental Biology, University of Michigan, USA,
personal communication), ML-SI3 (a kind gift from Haoxing Xu),
MK6-83 synthesised as described previously (Chen et al., 2014), GPN
(Santa Cruz Biotechnology), BTP2 (Sigma), thapsigargin (Merck), 2-
aminoethoxydiphenyl borate (2-APB, Sigma). Where indicated, Ca2+ was
omitted from the HBS (nominally Ca2+-free) or replaced with 1 mM EGTA
(Ca2+-free). For Fe2+ or Fe3+ quench experiments, cells were stimulated using
freshly prepared 100 mM stock solutions of either FeCl2 or FeCl3 (Sigma).
The maximal fluorescence ratio change (Ca2+) or the fractional quench at
360 nm excitation (Fe2+ or Fe3+) were quantified on an individual cell basis
and averaged for all cells in a given field of view. Experiments were repeated
at least three times and all individual data points plotted. The total number of
cells analysed is stated in the legends.
Confocal microscopy
Confocal images were captured using an LSM510 confocal scanner (Zeiss)
attached to a Zeiss Axiovert 200M inverted microscope fitted with a 63×
Plan Apochromat water-immersion objective. DAPI, GFP and Lysotracker®
Red or mRFP were excited at 364 nm, 488 nm and 543 nm, and emitted
fluorescence was captured using 385–470 nm, 505–550 nm and 560–
615 nm band-pass filters, respectively. Pearson’s correlation coefficients
were calculated from z-stacks (1-µm intervals, 8–12 slices) using the ImageJ
plugin Coloc2. The fraction of colocalised vesicles was calculated from the
middle slice or slices using the ImageJ plugin SQUASSH.
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Grimm, C., Jörs, S., Saldanha, S. A., Obukhov, A. G., Pan, B., Oshima, K.,
Cuajungco, M. P., Chase, P., Hodder, P. and Heller, S. (2010). Small molecule
activators of TRPML3. Chem. Biol. 17, 135-148.
Grimm, C., Hassan, S., Wahl-Schott, C. and Biel, M. (2012). Role of TRPML and
two-pore channels in endo-lysosomal cation homeostasis. J. Pharmacol. Exp.
Ther. 342, 236-244.
He, L.-P., Hewavitharana, T., Soboloff, J., Spassova, M. A. and Gill, D. L. (2005).
A functional link between store-operated and TRPC channels revealed by the 3,5-
bis(trifluoromethyl)pyrazole derivative, BTP2. J. Biol. Chem. 280, 10997-11006.
Hockey, L. N., Kilpatrick, B. S., Eden, E. R., Lin-Moshier, Y., Brailoiu, G. C.,
Brailoiu, E., Futter, C., Schapira, A. H., Marchant, J. S. and Patel, S. (2015).
Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by
TPC2 inhibition. J. Cell Sci. 128, 232-238.
Jadot, M., Colmant, C., Wattiaux-De Coninck, S. and Wattiaux, R. (1984).
Intralysosomal hydrolysis of glycyl-L-phenylalanine 2-naphthylamide.Biochem. J.
219, 965-970.
Kilpatrick, B. S., Eden, E. R., Schapira, A. H., Futter, C. E. and Patel, S. (2013).
Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals. J. Cell Sci.
126, 60-66.
Kim, H. J., Li, Q., Tjon-Kon-Sang, S., So, I., Kiselyov, K. and Muallem, S. (2007).
Gain-of-function mutation in TRPML3 causes the mouse Varitint-Waddler
phenotype. J. Biol. Chem. 282, 36138-36142.
Kiselyov, K. K., Ahuja, M., Rybalchenko, V., Patel, S. and Muallem, S. (2012).
The intracellular Ca2+ channels of membrane traffic. Channels (Austin). 6,
344-351.
Lee, J.-H., McBrayer, M. K., Wolfe, D. M., Haslett, L. J., Kumar, A., Sato, Y., Lie,
P. P. Y., Mohan, P., Coffey, E. E., Kompella, U. et al. (2015). Presenilin 1
maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-
mediated lysosome acidification. Cell Rep. 12, 1430-1444.
Lloyd-Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence,
D. J., Churchill, G. C., Schuchman, E. H., Galione, A. and Platt, F. M. (2008).
Niemann-Pick disease type C1 is a sphingosine storage disease that causes
deregulation of lysosomal calcium. Nat. Med. 14, 1247-1255.
McCue, H. V., Wardyn, J. D., Burgoyne, R. D. and Haynes, L. P. (2013).
Generation and characterization of a lysosomally targeted, genetically encoded
Ca2+-sensor. Biochem. J. 449, 449-457.
Medina, D. L., Di Paola, S., Peluso, I., Armani, A., De Stefani, D., Venditti, R.,
Montefusco, S., Scotto-Rosato, A., Prezioso, C., Forrester, A. et al. (2015).
Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB.
Nat. Cell Biol. 17, 288-299.
Melchionda, M., Pittman, J. K., Mayor, R. and Patel, S. (2016). Ca2+/H+ exchange
by acidic organelles regulates cell migration in vivo. J. Cell Biol. 212, 803-813.
Park, S., Ahuja, M., Kim, M. S., Brailoiu, G. C., Jha, A., Zeng, M., Baydyuk, M.,
Wu, L.-G., Wassif, C. A., Porter, F. D. et al. (2016). Fusion of lysosomes with
secretory organelles leads to uncontrolled exocytosis in the lysosomal storage
disease mucolipidosis type IV. EMBO Rep. 17, 266-278.
Patel, S. (2015). Function and dysfunction of two-pore channels. Sci. Signal. 8, re7.
Patel, S. and Brailoiu, E. (2012). Triggering of Ca2+ signals by NAADP-gated two-
pore channels: a role for membrane contact sites? Biochem. Soc. Trans. 40,
153-157.
Patel, S. and Cai, X. (2015). Evolution of acid Ca2+ stores and their resident Ca2+-
permeable channels. Cell Calcium 57, 222-230.
Patel, S. and Muallem, S. (2011). Acidic Ca2+ stores come to the fore. Cell Calcium
50, 109-112.
Patel, S., Marchant, J. S. and Brailoiu, E. (2010). Two-pore channels: Regulation
by NAADP and customized roles in triggering calcium signals. Cell Calcium 47,
480-490.
Penny, C. J., Kilpatrick, B. S., Han, J. M., Sneyd, J. and Patel, S. (2014). A
computational model of lysosome-ER Ca2+ microdomains. J. Cell Sci. 127,
2934-2943.
Prakriya, M. and Lewis, R. S. (2015). Store-operated calcium channels. Physiol.
Rev. 95, 1383-1436.
Pryor, P. R., Mullock, B. M., Bright, N. A., Gray, S. R. and Luzio, J. P. (2000). The
role of intraorganellar Ca2+ in late endosome–lysosome heterotypic fusion and in
the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149, 1053-1062.
Samie, M., Wang, X., Zhang, X., Goschka, A., Li, X., Cheng, X., Gregg, E., Azar,
M., Zhuo, Y., Garrity, A. G. et al. (2013). A TRP channel in the lysosome
regulates large particle phagocytosis via focal exocytosis. Dev. Cell 26, 511-524.
Shen, D., Wang, X., Li, X., Zhang, X., Yao, Z., Dibble, S., Dong, X.-P., Yu, T.,
Lieberman, A. P., Showalter, H. D. et al. (2012). Lipid storage disorders block
lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release.
Nat. Commun. 3, 731.
Sherer, N. M., Lehmann, M. J., Jimenez-Soto, L. F., Ingmundson, A., Horner,
S. M., Cicchetti, G., Allen, P. G., Pypaert, M., Cunningham, J. M. and Mothes,
W. (2003). Visualization of retroviral replication in living cells reveals budding into
multivesicular bodies. Traffic 4, 785-801.
Venkatachalam, K., Hofmann, T. andMontell, C. (2006). Lysosomal localization of
TRPML3 depends on TRPML2 and the mucolipidosis-associated protein
TRPML1. J. Biol. Chem. 281, 17517-17527.
Vergarajauregui, S. and Puertollano, R. (2006). Two di-leucine motifs regulate
trafficking of mucolipin-1 to lysosomes. Traffic 7, 337-353.
Waller-Evans, H. and Lloyd-Evans, E. (2015). Regulation of TRPML1 function.
Biochem. Soc. Trans. 43, 442-446.
Yamaguchi, S., Jha, Y., Li, Q., Soyombo, A. A., Dickinson, G. D., Churamani, D.,
Brailoiu, E., Patel, S. and Muallem, S. (2011). Transient receptor potential
mucolipin 1 (TRPML1) and two-pore channels are functionally independent
organellar ion channels. J. Biol. Chem. 286, 22934-22942.
Zhang, F., Xu, M., Han, W.-Q. and Li, P.-L. (2011). Reconstitution of lysosomal
NAADP-TRP-ML1 signaling pathway and its function in TRP-ML1−/− cells.
Am. J. Physiol. Cell Physiol. 301, C421-C430.
Zhang, X., Li, X. and Xu, H. (2012). Phosphoinositide isoforms determine
compartment-specific ion channel activity. Proc. Natl. Acad. Sci. USA 109,
11384-11389.
3867
RESEARCH ARTICLE Journal of Cell Science (2016) 129, 3859-3867 doi:10.1242/jcs.190322
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
